Platelet Aggregation in Diabetes

Diabetes is associated with increased platelet aggregation, which significantly raises the risk of cardiovascular complications. Elevated blood glucose levels and hyperlipidemia can lead to changes in platelet function and activation. Factors such as oxidative stress and chronic inflammation in diabetic patients can promote a pro-thrombotic state, increasing the likelihood of thrombosis. This heightened platelet reactivity contributes to the development of atherosclerosis, leading to conditions like heart attacks and strokes. Understanding the mechanisms underlying platelet aggregation in diabetes is vital for developing targeted therapies that can reduce cardiovascular risk in these patients.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp